Only about one in every 170 children take them. But 'orphan drugs' accounted for 1 in every 15 private insurance dollars spent on children's health care in the United States in 2018, according to a new study. That's up 65% ...
Oct 6, 2020
0
9
(HealthDay)—Since the passage of "Obamacare," fewer Americans are facing insurmountable medical bills—but the benefit does not seem to be reaching people with private insurance, a new study shows.
Sep 30, 2020
0
2
Modifiable health risks, such as obesity, high blood pressure, and smoking, were linked to over $730 billion in health care spending in the US in 2016, according to a study published in The Lancet Public Health. Researchers ...
Sep 30, 2020
0
0
One-third of the people who could benefit from a special type of savings account to cushion the blow of their health plan deductible aren't doing so, according to a new study.
Aug 13, 2020
0
4
The coronavirus pandemic has highlighted the numerous weaknesses in the U.S. healthcare system. Millions have lost their health insurance and millions more can barely afford it. Racial, ethnic, economic, and geographic disparities ...
Aug 5, 2020
0
13
A new study from the University of Georgia finds that users of public insurance are paying more for bariatric weight loss surgery compared to private insurance patients.
Jul 13, 2020
0
0
The COVID-19 pandemic has cost California's public and private insurers an estimated $2.4 billion dollars in testing and treatment—about six times the annual cost to treat seasonal influenza in the state, according to a ...
Jun 26, 2020
0
7
A preference by Indonesians to seek initial care for tuberculosis (TB) at private clinics rather than public facilities is resulting in diagnostic delays and escalated costs, says a new study.
Jun 22, 2020
0
0
A new American Cancer Society study finds higher medical and nonmedical financial hardships are independently associated with more emergency department visits, lower receipt of some preventive services, and worse self-rated ...
Jun 18, 2020
0
1
Nearly 9 in 10 U.S. adults are "very" (55%) or "somewhat" (33%) concerned that the pharmaceutical industry will leverage the COVID-19 pandemic to raise drug prices. Similarly, 84% are very or somewhat concerned that the general ...
Jun 18, 2020
0
1
